Test of Chamber Pressure to Divers and Chamber Attendants (TOP-DIVER)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Intermountain Health Care, Inc.
ClinicalTrials.gov Identifier:
NCT01430325
First received: September 2, 2011
Last updated: February 12, 2013
Last verified: December 2012

September 2, 2011
February 12, 2013
July 2011
October 2011   (final data collection date for primary outcome measure)
  • Participants Indicating "I do Not Know" on Depth Questionnaire. [ Time Frame: Within 15 minutes of chamber excursion ] [ Designated as safety issue: No ]
    Participants indicating "I do not know" on depth questionnaire instead of providing a free response guess.
  • Participant Perception of Depth [ Time Frame: Within 15 minutes of chamber excursion ] [ Designated as safety issue: No ]
    Mean depth perception for participants providing a free response.
  • Participant Perception of Breathing Gas [ Time Frame: Within 15 minutes of chamber excursion ] [ Designated as safety issue: No ]
    Percent of participants in each arm guessing that their breathing gas was 100% oxygen.
Blinding Questionnaires [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]
Two questionnaires requesting participant perception of chamber pressure and breathing gas (free response and forced multiple-choice).
Complete list of historical versions of study NCT01430325 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Test of Chamber Pressure to Divers and Chamber Attendants
Test of Chamber Pressure to Divers and Chamber Attendants: A Blinded Trial to Investigate if "Pressure-familiar" Individuals Can Determine Pressure

SCUBA divers and chamber inside attendants will undergo a brief hyperbaric chamber excursion and will be asked to what chamber pressure they were compressed and what gas they breathed.

In clinical trials evaluating hyperbaric oxygen, blinding can be challenging. Options for participant blinding include offering regular air at a lower pressure than the hyperbaric oxygen intervention, or compressing all participants to the same pressure but providing different gas mixes to the active and sham arms.

In some trials of hyperbaric oxygen for brain injury, investigators offer a sham chamber session (regular air at 1.2 atmospheres absolute [atm abs]) compared to the active intervention, hyperbaric oxygen (100% oxygen at 1.5 atm abs). It is unknown whether individuals familiar with pressure changes, such as divers and hyperbaric chamber inside attendants, could discern the difference between these pressures and thereby become unblinded to study allocation.

In this study, 80 experienced divers and chamber inside attendants will be enrolled and randomly assigned to one of four possible chamber pressures and one of two breathing gases. After a brief hyperbaric chamber excursion, they will be asked to what chamber pressure they were compressed and what gas they breathed. If participants can accurately report chamber pressure or breathing gas, pressure-familiar individuals should be excluded from blinded clinical trials of hyperbaric oxygen.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Traumatic Brain Injury
  • Drug: Hyperbaric Oxygen (1.5 atm abs)
    Hyperbaric oxygen (100% oxygen) delivered at a chamber pressure of 1.5 atm abs.
    Other Names:
    • HBO2
    • HBO
    • HBOT
  • Drug: Sham Chamber Session
    Sham control chamber session: regular air delivered at a chamber pressure of 1.2 atm abs
    Other Names:
    • Sham control
    • Air pressurization
  • Sham Comparator: Sea Level Equivalent 1.2 atm abs (air)

    Sham Chamber Session

    Sea Level Equivalent 1.2 atm abs (2.6 psig) breathing regular air 20-chamber excursion

    Intervention: Drug: Sham Chamber Session
  • Experimental: Sea Level Equivalent 1.5 atm abs (O2)

    Hyperbaric Oxygen (1.5 atm abs)

    Sea Level Equivalent 1.5 atm abs (6.2 psig) breathing 100% oxygen 20-minute chamber excursion

    Intervention: Drug: Hyperbaric Oxygen (1.5 atm abs)
  • Sham Comparator: Altitude Equivalent 1.2 atm abs (air)

    Sham Chamber Session

    Altitude Equivalent 1.2 atm abs (5.1 psig) breathing regular air 20-minute chamber excursion

    Intervention: Drug: Sham Chamber Session
  • Experimental: Altitude Equivalent 1.5 atm abs (O2)

    Hyperbaric Oxygen (1.5 atm abs)

    Altitude Equivalent 1.5 atm abs (9.6 psig) breathing 100% oxygen 20-minute chamber excursion

    Intervention: Drug: Hyperbaric Oxygen (1.5 atm abs)

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
42
October 2011
October 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Adult, age 18 - 65 years
  • Completion of medical history questionnaire without concerns identified for exposure to increased pressure
  • Familiarity with atmospheric pressure change:
  • Experienced and active hyperbaric chamber inside attendant: more than 50 hyperbaric compressions, with more than 4 have been in the last 4 months; or
  • Experienced and active SCUBA diver: more than 20 lifetime compressed gas open water (not swimming pool) dives, with more than 10 in the last 12 months
  • Able to equalize middle ear pressure easily

Exclusion Criteria:

  • Pregnancy
  • Known risk for barotrauma, as identified on the medical history questionnaire, such as:
  • Recent (within 12 months) inner ear or sinus surgery
  • Spontaneous pneumothorax
  • Pulmonary cysts
  • Emphysema
  • Bullous lung disease
  • Chronic obstructive pulmonary disease needing chronic active therapy
  • Inability to tolerate chamber confinement or pressure
  • Presence of heart failure
  • Presence of any implanted electrical device, except hyperbaric-approved pacemakers
  • Presence of middle-ear tympanostomy tubes
Both
18 Years to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01430325
1023955
No
Intermountain Health Care, Inc.
Intermountain Health Care, Inc.
Not Provided
Principal Investigator: Lindell K. Weaver, MD Intermountain Health Care, Inc.
Intermountain Health Care, Inc.
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP